Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Exo-1, Vesicular trafficking inhibitor (ab120292)

Price and availability

241 228 ₸

Availability

Order now and get it on Friday March 05, 2021

Exo-1, Vesicular trafficking inhibitor (ab120292)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Vesicular trafficking inhibitor
  • CAS Number: 461681-88-9
  • Purity: > 99%
  • Soluble in DMSO to 100 mM and in ethanol to 25 mM
  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Product image
Recombinant Mouse PSCA protein (His tag) (ab241245)
Product image
Anti-BubR1 antibody (ab70544)
Recombinant Human ARSA/ASA protein (ab151369)
Product image
Recombinant mouse SCF protein (Active) (ab269179)

Overview

  • Product name

    Exo-1, Vesicular trafficking inhibitor
  • Description

    Vesicular trafficking inhibitor
  • Biological description

    Cell-permeable, reversible inhibitor of vesicular trafficking between endoplasmic reticulum and the Golgi apparatus. Inhibits exocytosis with an IC50 of approx. 20 μM. Rapidly releases Arf1 from Golgi membranes. Has similar mechanism of action to brefeldin A (ab120299).

  • Purity

    > 99%
  • CAS Number

    461681-88-9
  • Chemical structure

    Chemical Structure

Properties

  • Chemical name

    Methyl 2-(4-fluorobenzamido)benzoate
  • Molecular weight

    273.26
  • Molecular formula

    C15H12FNO3
  • PubChem identifier

    310557
  • Storage instructions

    Store at Room Temperature. The product can be stored for up to 12 months.
  • Solubility overview

    Soluble in DMSO to 100 mM and in ethanol to 25 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILES

    O=C(Nc1ccccc1C(=O)OC)c2ccc(F)cc2
  • Source

    Synthetic

  • Research areas

    • Cardiovascular
    • Lipids / Lipoproteins
    • Lipid Metabolism
    • Cytochromes
    • Signal Transduction
    • Metabolism
    • Drug metabolism
    • Biochemicals
    • Chemical Type
    • Biochemicals
    • Biochemicals
    • Pharmacology
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Lipid and lipoprotein metabolism
    • Lipases
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Drug metabolism
    • Metabolism
    • Pathways and Processes
    • Mitochondrial Metabolism
    • Cytochromes
    • Biochemicals
    • Research Area
    • Heart disease
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Pain & inflammation
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Alzheimer's Disease
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Alzheimer's Disease
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Diabetes
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Diabetes
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Heart disease
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Hypertension
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Hypertension
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Obesity
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Obesity
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Pain & inflammation
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Respiratory disease
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Respiratory disease
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Stroke
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Stroke
    • Signaling
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Pharmacology
    • Signaling
    • Cytoskeleton & motor proteins
    • Other
    • Biochemicals
    • Research Area
    • Cancer
    • Cytoskeleton & motor proteins
    • Inhibitors
    • Biochemicals
    • Research Area
    • Cancer
    • Cytoskeleton & motor proteins
    • Other

Images

  • Functional Studies - Exo-1, Vesicular trafficking inhibitor (ab120292)
    Functional Studies - Exo-1, Vesicular trafficking inhibitor (ab120292)
    ab86071 staining GBF1 in HeLa cells treated with Exo-1 (ab120292), by ICC/IF. Increase in GBF1 expression correlates with increased concentration of Exo-1 as described in literature.
    The cells were incubated at 37°C for 5 minutes in media containing different concentrations of ab120292 ( Exo-1) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab86071 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Beta Arrestin 2 antibody (ab54790)

  •  
  • Product image

    Anti-Beta Arrestin 2 antibody [EPR22073] (ab206972)

  •  
  • Product image

    Anti-Neurocan antibody [EPR6397] (ab125021)

  •  
  • Product image

    Anti-GABA Transporter 1 / GAT 1 antibody [EPR12999(2)] (ab185205)

  •  
  • Product image

    Anti-Azurocidin antibody [EPR9503] - BSA and Azide free (ab250556)

  •  
  • Product image

    Anti-Surfactant protein D/SP-D antibody (ab203309)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.